Extracellular ATP increases L-carnitine transport and content in C2C12 cells

Pharmacology

Volumn 81, Issue 3, 2008, Pages 246-250

  Rigault, Caroline ^a   Bernard, Arnaud ^a   Georges, Béatrice ^a   Kandel, Adeline ^a   Pfützner, Elisabeth ^a   Le Borgne, Françoise ^a   Demarquoy, Jean ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

C2C12 cells; L Carnitine transporter activity; Nucleotide; P2X receptor; P2Y receptor; Skeletal muscle

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMINO ACID TRANSPORTER; CARNITINE; LINOLEIC ACID; PURINERGIC P2X RECEPTOR; PURINERGIC P2Y RECEPTOR;

AMINO ACID METABOLISM; AMINO ACID TRANSPORT; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; FATTY ACID TRANSPORT; MOUSE; MUSCLE CONTRACTION; MUSCLE METABOLISM; MYOBLAST; NONHUMAN; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATE; ANIMALS; BIOLOGICAL TRANSPORT; CARNITINE; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MICE; MYOBLASTS; RECEPTORS, PURINERGIC P2; VITAMIN B COMPLEX;

EID: 41349089310     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000114449     Document Type: Article

References (29)

1. Volonté C, Amadio S, Cavaliere F, D'Ambrosi N, Vacca F, Bernardi G: Extracellular ATP and neurodegeneration. Curr Drug Targets CNS Neurol Disord 2003;2:403-412.
2. Köles L, Fürst S, Illes P: Purine ionotropic (P2X) receptors. Curr Pharm Des 2007;13:2368-2384.
3. Dubyak GR, el-Moatassim C: Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am J Physiol 1993;265(3 Pt 1):C577-C606.
4. Li J, King NC, Sinoway LI: ATP concentrations and muscle tension increase linearly with muscle contraction. J Appl Physiol 2003;95:577-583.
5. Kennedy C, McLaren GJ, Westfall TD, Sneddon P: ATP as a co-transmitter with noradrenaline in sympathetic nerves - function and fate. Ciba Found Symp 1996;198:223-235; discussion 235-238.
6. Redegeld FA, Caldwell CC, Sitkovsky MV: Ecto-protein kinases: ecto-domain phosphorylation as a novel target for pharmacological manipulation? Trends Pharmacol Sci 1999;20:453-459.
7. Ziganshin AU, Ziganshina LE, Burnstock G: P2 receptors: theoretical background for the use in clinical practice. Bull Exp Biol Med 2002;134:313-317.
8. Valera S, Hussy N, Evans RJ, Adami N, North RA, Surprenant A, Buell G: A new class of ligand-gated ion channel defined by P2x receptor for extracellular ATP. Nature 1994;371:516-519.
9. North RA: Families of ion channels with two hydrophobic segments. Curr Opin Cell Biol 1996;8:474-483.
10. Vassort G: Adenosine 5′-triphosphate: a P2-purinergic agonist in the myocardium. Physiol Rev 2001;81:767-806.
11. Rasmussen BB, Wolfe RR: Regulation of fatty acid oxidation in skeletal muscle. Annu Rev Nutr 1999;19:463-484.
12. Demarquoy J, Georges B, Rigault C, Royer MC, Clairet A, Soty M, Lekounoungou S, Le Borgne F: Radioisotopic determination of L-carnitine content in foods commonly eaten in Western countries. Food Chem 2004;86:137-142.
13. Rigault C, Mazué F, Bernard A, Demarquoy J, Le Borgne F: Changes in l-carnitine content of fish and meat during domestic cooking. Meat Sci, in press.
14. Galland S, Le Borgne F, Bouchard F, Georges B, Clouet P, Grand-Jean F, Demarquoy J: Molecular cloning and characterization of the cDNA encoding the rat liver gamma-butyrobetaine hydroxylase. Biochim Biophys Acta 1999;1441:85-92.
15. Georges B, Le Borgne F, Galland S, Isoir M, Ecosse D, Grand-Jean F, Demarquoy J: Carnitine transport into muscular cells. Inhibition of transport and cell growth by mildronate. Biochem Pharmacol 2000;59:1357-1363.
16. Kiens B, Roepstorff C: Utilization of longchain fatty acids in human skeletal muscle during exercise. Acta Physiol Scand 2003;78:391-396.
17. Wu X, Prasad PD, Leibach FH, Ganapathy V: cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family. Biochem Biophys Res Commun 1998;246:589-595.
18. Brass EP, Scarrow AM, Ruff LJ, Masterson KA, Van Lunteren E: Carnitine delays rat skeletal muscle fatigue in vitro. J Appl Physiol 1993;75:1595-1600.
19. Georges B, Galland S, Rigault C, Borgne F, Demarquoy J: Beneficial effects of L-carnitine in myoblastic C2C12 cells. Interaction with zidovudine. Biochem Pharmacol 2003;65:1483-1488.
20. McMahon DK, Anderson PA, Nassar R, Bunting JB, Saba Z, Oakeley AE, Malouf NN: C2C12 cells: biophysical, biochemical, and immunocytochemical properties. Am J Physiol 1994;266(6 Pt 1):C1795-C1802.
21. Gauthier-Rouviere C, Vandromme M, Tuil D, Lautredou N, Morris M, Soulez M, Kahn A, Fernandez A, Lamb N: Expression and activity of serum response factor is required for expression of the muscle-determining factor MyoD in both dividing and differentiating mouse C2C12 myoblasts. Mol Biol Cell 1996;7:719-729.
22. Novak I: ATP as a signaling molecule: the exocrine focus. News Physiol Sci 2003;18:12-17.
23. 12 skeletal muscle cells. Arch Biochem Biophys 2002;401:205-214.
24. Galland S, Le Borgne F, Guyonnet D, Clouet P, Demarquoy J: Purification and characterization of the rat liver gamma-butyrobetaine hydroxylase. Mol Cell Biochem 1998;178:163-168.
25. Itzhaki RF, Gill DM: A micro-biuret method for estimating proteins. Anal Biochem 1964;9:401-410.
26. Gustafson B, Ransnäs LA: Regulation of carnitine binding to plasma membranes by an ATP-dependent mechanism. Biochem Biophys Res Commun 1997;231:249-253.
27. Müller CE: P2-pyrimidinergic receptors and their ligands. Curr Pharm Des 2002;8:2353-2369.
28. Bacurau RF, Navarro F, Bassit RA, Meneguello MO, Santos RV, Almeida AL, Costa Rosa LF: Does exercise training interfere with the effects of L-carnitine supplementation? Nutrition 2003;19:337-341.
29. Capecchi PL, Laghi Pasini F, Quartarolo E, Di Perri T: Carnitines increase plasma levels of adenosine and ATP in humans. Vasc Med 1997;2:77-81.